# Carbetocin vs Misoprostol for Postpartum Hemorrhage Prevention

> **NCT07353281** · NA · NOT_YET_RECRUITING · sponsor: **Western Galilee Hospital-Nahariya** · enrollment: 146 (estimated)

## Conditions studied

- Postpartum Complication
- Postpartum Hemorrhage

## Interventions

- **DRUG:** Carbetocin 100 Microgram/mL Solution for Injection
- **DRUG:** Misoprostol

## Key facts

- **NCT ID:** NCT07353281
- **Lead sponsor:** Western Galilee Hospital-Nahariya
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-31
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 146 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07353281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07353281, "Carbetocin vs Misoprostol for Postpartum Hemorrhage Prevention". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07353281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*